Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND3 | P30281 | 20/20 | 0.48 |
| ▸ | CDK6 | Q00534 | 20/20 | 0.48 |
| ▸ | CDK4 | P11802 | 19/20 | 0.48 |
| ▸ | CCND1 | P24385 | 19/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26341659 | 0.88 | CCND3 (0.48) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26343826 | 0.87 | CCND3 (0.51) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26340984 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26342057 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26341633 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26341682 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26341558 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26341635 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26340986 | 0.83 | CDK6 (0.46) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL26340974 | 0.78 | CCND3 (0.47) | CCND3CDK6CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303564-A1 | PYRIMIDINE RING COMPOUND | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230303564-A1 | PYRIMIDINE RING COMPOUND | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. (CN) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303564-A1 | PYRIMIDINE RING COMPOUND | DPYD, TYMS, TYMP | CCND3 673/4885CDK6 221/4885CDK4 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.